Parkinson's disease and parkinsonism - Injection with the heroin contaminant MPTP Factor
Last reviewed for CCPS 26 September 2007.
Investigative Documents
Claimant Report - Injection Containing MPTP - Parkinson's Disease and Parkinsonism [CR9162]Preliminary questions [23253]
23343
there is some evidence that an injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) may be a factor in the development or worsening of the condition under consideration.
23346 — the veteran has established the causal connection between the injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and VEA service for Parkinson's disease or parkinsonism.
23347 — the veteran has established the causal connection between the injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and VEA service for the clinical onset of parkinsonism.
23349 — the veteran has established the causal connection between the injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and operational service for the clinical onset of parkinsonism.
or
23350 — the veteran has established the causal connection between the injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and eligible service for the clinical onset of parkinsonism.
or
7334 the clinical onset of the condition under consideration occurred after the end of the veteran's last period of VEA service.7335
the condition under consideration permanently worsened.23348 — the veteran has established the causal connection between the injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and VEA service for the clinical worsening of Parkinson's disease or parkinsonism.
23351 — the veteran has established the causal connection between the injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and operational service for the clinical worsening of Parkinson's disease or parkinsonism.
or
23352 — the veteran has established the causal connection between the injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and eligible service for the clinical worsening of Parkinson's disease or parkinsonism.
Clinical onset and operational service [23349]
38596 — the veteran has parkinsonism.
23410
on operational service, the veteran received an injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).25075
on operational service, the veteran received an injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) within the 90 days before the clinical onset of the condition under consideration.23411
the injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) that the veteran received on operational service within the 90 days before the clinical onset of the condition under consideration was due to the veteran's serious default, wilful act or serious breach of discipline.or
23345
the veteran received an injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) as a result of an illness or injury which is identifiable.23353
the veteran received an injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) as a result of the identified illness or injury within the 90 days before the clinical onset of the condition under consideration.23355 — the identified illness or injury as a result of which the injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) was received is causally related to operational service.
Clinical onset and eligible service [23350]
38596 — the veteran has parkinsonism.
38680
on eligible service, the veteran received an injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).38681
as a causal result of eligible service, the veteran received an injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).38683
as a causal result of eligible service, the veteran received an injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) within the 90 days before the clinical onset of the condition under consideration.38686
the injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) that the veteran received on eligible service within the 90 days before the clinical onset of the condition under consideration was due to the veteran's serious default, wilful act or serious breach of discipline.or
23345
the veteran received an injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) as a result of an illness or injury which is identifiable.23353
the veteran received an injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) as a result of the identified illness or injury within the 90 days before the clinical onset of the condition under consideration.23356 — the identified illness or injury as a result of which the injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) was received is causally related to eligible service.
Clinical worsening and operational service [23351]
23410
on operational service, the veteran received an injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).38682
as a causal result of operational service, the veteran received an injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).38684
as a causal result of operational service, the veteran received an injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) within the 90 days before the clinical worsening of the condition under consideration.38687
the injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) that the veteran received on operational service within the 90 days before the clinical worsening of the condition under consideration was due to the veteran's serious default, wilful act or serious breach of discipline.or
23345
the veteran received an injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) as a result of an illness or injury which is identifiable.23354
the veteran received an injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) as a result of the identified illness or injury within the 90 days before the clinical worsening of the condition under consideration.23355 — the identified illness or injury as a result of which the injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) was received is causally related to operational service.
23357
the clinical onset of the condition under consideration occurred prior to that part of operational service to which the identified illness or injury as a result of which the injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) was received is causally related.Clinical worsening and eligible service [23352]
38680
on eligible service, the veteran received an injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).38681
as a causal result of eligible service, the veteran received an injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).38685
as a causal result of eligible service, the veteran received an injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) within the 90 days before the clinical worsening of the condition under consideration.38688
the injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) that the veteran received on eligible service within the 90 days before the clinical worsening of the condition under consideration was due to the veteran's serious default, wilful act or serious breach of discipline.or
23345
the veteran received an injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) as a result of an illness or injury which is identifiable.23354
the veteran received an injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) as a result of the identified illness or injury within the 90 days before the clinical worsening of the condition under consideration.23356 — the identified illness or injury as a result of which the injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) was received is causally related to eligible service.
23358
the clinical onset of the condition under consideration occurred prior to that part of eligible service to which the identified illness or injury as a result of which the injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) was received is causally related.